#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer recurrent Marginal zone lymphoma refractory Primary amyloidosis Pulmonary alveolar haemorrhage Osteosarcoma Chronic myeloid leukaemia (in remission) T-cell type acute leukaemia Fms-like tyrosine kinase 3 positive Squamous cell carcinoma of the cervix Nephroblastoma Vulval cancer recurrent Anal fistula Hereditary hypophosphataemic rickets Pleomorphic leiomyosarcoma Multifocal motor neuropathy More trials…

    Learn about Rare Diseases

    Haemophilia – Basic Information Paroxysmal nocturnal haemoglobinuria – Treatment Urea cycle disorder – Trials in Disease Vascular malformation – Diagnostics Mucopolysaccharidosis I – Diagnostics Hereditary optic atrophy Langerhans cell sarcoma – Treatment Osteosarcoma – Life with Disease Bronchiolitis obliterans syndrome – Life with Disease Basal cell naevus syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Islatravir L-Ascorbic Acid Nesolicaftor Niraparib Tosilate Monohydrate Ro7247669 ASP2957 Tenecteplase Hydroxypropyl Cellulose Lf Epirubicin Io103 Acetate Fluasterone Doconexent Rebisufligene Etisparvovec Indapamide Tulmimetostat Diclofenac Diethylamine Cyclophosphamide Monohydrate Pertuzumab Izorlisib Mesilate Quercus Ilex Allergen Extract More therapies…

    Learn about Your Condition

    Diabetes insipidus Cardiac failure chronic Dyspepsia Eye inflammation Mumps Stargardt's disease End stage renal disease Basal cell naevus syndrome Phaeochromocytoma Haemoptysis Vaginal cancer Lichen planopilaris Nephroblastoma Follicular lymphoma stage IV Testicular germ cell tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Colchicine for Treating Patients with Inflammatory Cardiomyopathy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Colchicine
    Italy

  • Study on the Effectiveness of Valganciclovir for Patients with Glioblastoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Valganciclovir
    Norway Sweden

  • Study of Durvalumab, Cisplatin, Carboplatin, and Etoposide for Patients with Extensive Stage Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • Durvalumab
    • Carboplatin
    • Cisplatin
    Germany

  • Study on Daratumumab, Carfilzomib, Pomalidomide, and Dexamethasone for Patients with Multiple Myeloma and Acute Kidney Failure

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Carfilzomib
    • Daratumumab
    • Dexamethasone
    Austria

  • Study on Apremilast for Patients with Severe Recurrent Mouth Ulcers Resistant to Colchicine

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Stomatitis
    Investigated Drugs:
    • Apremilast
    France

  • Safety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne

    Not yet recruiting

    2 1
    Germany Poland Spain
Previous Page
1 … 906 907 908 909 910 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!